Clinical Trial Update: Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ivabradine's effect on inflammatory markers in patients with acute coronary syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Hospital Universitario de Canarias | Conditions: Acute Coronary Syndromes | Phase 4 | Status: COMPLETED